6
Clinical Trials associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)A Multicenter, Randomized, Double-blind, Controlled Phase III Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells (AlloJoin®) Therapy for Knee Osteoarthritis.
Evaluate the efficacy and safety of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy
A Multicenter, Randomized, Double-blind, Controlled Phase III Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells (AlloJoin®) Therapy for Knee Osteoarthritis.
Evaluate the efficacy and safety of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy
A Multicenter, Randomized, Double-blind, Controlled Phase II Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells (AlloJoin®) for the Treatment of Knee Osteoarthritis
Evaluate the efficacy and safety of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy
100 Clinical Results associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)
100 Translational Medicine associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)
100 Patents (Medical) associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)
100 Deals associated with Allogeneic human adipose-derived mesenchymal stem cell therapy (Cellular Biomedicine Group)